Immediate Impact

1 by Nobel laureates 61 standout
Sub-graph 1 of 22

Citing Papers

From periphery to center stage: 50 years of advancements in innate immunity
2024 Standout
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
3 intermediate papers

Works of Yaovalux Chamgramol being referenced

Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma
2012
Comparison of gene expression profiles between Opisthorchis viverrini and non‐Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma†
2006

Author Peers

Author Last Decade Papers Cites
Yaovalux Chamgramol 313 195 172 310 34 660
Apinya Jusakul 315 165 173 279 45 609
Krishna Patel 192 256 178 300 42 709
Kawin Leelawat 366 266 179 270 43 759
Yoshihito Gomyo 261 297 126 346 25 780
Vânia Camilo 309 112 58 218 23 594
E. Mezza 279 156 69 250 27 703
Huabang Zhou 422 233 128 135 20 585
Sozaburo Ihara 207 167 68 316 36 757
Xing He 167 76 234 331 35 749
Md. Hafiz Uddin 70 215 211 461 44 748

All Works

Loading papers...

Rankless by CCL
2026